All news

Bina Innovation Fellowship - Cohort 3 - 2nd Session

Bina Fellowship Cohort 3 at Bina - Bridge Innovate Nurture Advance, The Weizmann Institute of Science

Session 2 took us from the investor lens to the incubator model and all the way to a founder’s journey.

Dr. Tamar Farfel-Becker, PhD (YEDA - Technology Transfer Company of Weizmann Institute of Science) unpacked the venture capital world and how opportunities look through an investor’s eyes - what matters, why timing and fit are key, and how to speak the language of value.

Dr. Dorit Rozner, PhD (The Kitchen Hub) shared how foodtech startups are built within an incubator model - what support looks like, how companies are selected, and how the platform helps teams de-risk and accelerate.

Dr. Yuval Gilad (FreezeM) shared the story of a Weizmann-born company that has grown into a unique model of its own. Now comprising 25 employees in Israel with very promising results! and walked us through the twists, turns, and lessons learned along the way.

Thank you Tamar, Dorit and Yuval for an eye-opening session!

Next to come: technology assessment tools.

More News

Bina Workshop For Students in the Weizmann MD-PhD Program.

Dr. Merav Marom and Dr. Ronny Peri Naor, project managers at Bina, Weizmann Institute of Science, had the pleasure of instructing a workshop for students in the Weizmann MD-PhD Program.
Our goal was to strengthen the foundations of research planning and experimental design. Rigorous design is what turns “interesting results” into reliable, reproducible data. We discussed a key translational challenge: many academic experiments fail to reproduce well when applied in an industry setting, which directly impacts the path from discovery to real-world impact. 

New Collaboration Project Was Approved by Bina Nurture Committee

Bina is pleased to announce the launch of a newly approved collaborative research project, which brings together expertise from two leading research institutions.
The project is a collaboration between Dr. Haim Barr, Head of the Maurice and Vivienne Wohl Institute for Drug Discovery at the Weizmann Institute of Science, and Prof. Yossi (Joseph) Tam from the Institute for Drug Research at the School of Pharmacy, The Hebrew University of Jerusalem.